We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Buried deep in the administration’s budget proposal are a series of drug price control measures that could rattle the pharmaceutical industry. Read More
The full Senate is scheduled to decide on Feb. 22 whether Robert Califf should be the next FDA commissioner, after Majority Leader Sen. Mitch McConnell (R-Ky.) scheduled a cloture vote late Thursday. Read More
European officials are pushing for greater synchronicity between the U.S. and EU regulators on generic approval processes as part of broader trade negotiations. Read More
In observance of Presidents' Day, Drug Industry Daily will not be published Monday, Feb. 15. The next issue will be published Tuesday, Feb. 16. Read More
The European Medicines Agency has accepted Sandoz’s MAA for its biosimilar to Amgen’s Neulesta to help the body make white blood cells after receiving cancer medications. Read More
Incyte has discontinued a Phase 3 trial of Jakafi with capecitabine as a second-line treatment for patients with metastatic pancreatic cancer after the combination failed to show sufficient efficacy. Read More
Adaptimmune Nabs Breakthrough Therapy for NY-ESO T-Cell Therapy
AbbVie’s Endometriosis Pain Candidate Meets Primary Endpoints in Phase 3
FDA Grants Priority Review to KemPharm Pain Candidate
Adcomm to Discuss Drug Compounding in March
Chugai’s ALK Inhibitor Trial Stopped Early Due to Benefit Read More